Seramune Oral
This page contains information on Seramune Oral for veterinary use.The information provided typically includes the following:
- Seramune Oral Indications
- Warnings and cautions for Seramune Oral
- Direction and dosage information for Seramune Oral
Seramune Oral
This treatment applies to the following species:For Failure of Passive Transfer in Neonatal Foals
Bottle contains one dose of 300ml.
Dose: Administer orally in two even amounts (150 mL each) 1-2 hours apart, within first 12 hours of life.
Protect from direct sunlight. Store refrigerated at 2°-7°C/36°-45°F. Do not freeze. Once opened, use entire contents as directed above.
Equine serum origin.
For use by or under the direction of a veterinarian.
Seramune Oral Indications
For the treatment of failure of passive transfer in neonatal foals.
Seramune Oral Caution
As with any serum product, adverse reactions may occur. In case of reactions, stop treatment and administer epinephrine.
U.S. Vet. Lic. No. 328
300ml
Sera, Inc., P.O. Box 15866, Shawnee Mission, Kansas, 66285-5866
NAC No.: 14980011
P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
| Telephone: | 913-541-1307 | |
| Toll-Free: | 800-552-3984 | |
| Fax: | 913-541-1712 | |
| Website: | www.seramune.com | |
| Email: | sera@everestkc.net |
 |
Every effort has been made to ensure the accuracy of the Seramune Oral information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert. |
Copyright © 2014 North American Compendiums. Updated: 2014-04-11
